A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample
A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample
复制标题
DOI：
10.1080/0959523031000154454
复制
发表时间：
2003-09-01
影响因子：
3.8
通讯作者：
Sellman, JD
中科院分区：
文献类型：
--
作者：
Adamson, SJ;Sellman, JD
大麻使用障碍识别测试（CUDIT）首次被用作一项随机对照试验的一部分，用于轻度至中度酒精依赖门诊患者的短暂干预。该样本可被视为大麻使用障碍风险增加的人群。CUDIT是通过修改酒精使用障碍识别测试（AUDIT）开发的。CUDIT准确筛查大麻滥用或依赖的能力在过去6个月报告一些大麻使用的样本部分（n = 53）中进行了检查，这是过去6个月自我报告的大麻使用频率。CUDIT是上级的频率测量，实现了84.6%的阳性预测能力和敏感性为73.3%，在截止值为8，相比之下，80个或更多的大麻使用天的阳性预测能力为81.8%，敏感性为60.0%。这些结果表明，在风险人群中识别大麻使用障碍的筛查措施的可行性。
The Cannabis Use Disorders Identification Test (CUDIT) was used for the first time as part of a randomized controlled trial for brief interventions in mild to moderate alcohol-dependent out-patients. This sample may be seen as a population at increased risk of cannabis use disorder. The CUDIT was developed by modifying the Alcohol Use Disorders Identification Test (AUDIT). The ability of the CUDIT to accurately screen for cannabis abuse or dependence was examined in the portion of the sample who reported some cannabis use over the preceding 6 months ( n = 53), as was self-reported frequency of cannabis use in the preceding 6 months. The CUDIT was superior to the frequency measure, achieving positive predictive power of 84.6% and sensitivity of 73.3% at a cut-off of 8, compared to positive predictive power of 81.8% and sensitivity of 60.0% for 80 or more cannabis use-days. These results indicate the viability of a screening measure for identifying cannabis use disorder in at risk populations.